These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28243775)

  • 1. Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands.
    Douven R; Katona K; T Schut F; Shestalova V
    Eur J Health Econ; 2017 Nov; 18(8):1047-1064. PubMed ID: 28243775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
    Pendzialek JB; Danner M; Simic D; Stock S
    Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.
    Duijmelinck DM; Mosca I; van de Ven WP
    Health Policy; 2015 May; 119(5):664-71. PubMed ID: 25530069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching health insurers: the role of price, quality and consumer information search.
    Boonen LH; Laske-Aldershof T; Schut FT
    Eur J Health Econ; 2016 Apr; 17(3):339-53. PubMed ID: 25820635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching rates in health insurance markets decrease with age: empirical evidence and policy implications from the Netherlands.
    Duijmelinck DM; van de Ven WP
    Health Econ Policy Law; 2016 Apr; 11(2):141-59. PubMed ID: 26173559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementary insurance as a switching cost for basic health insurance: Empirical results from the Netherlands.
    Willemse-Duijmelinck DMID; van de Ven WPMM; Mosca I
    Health Policy; 2017 Oct; 121(10):1085-1092. PubMed ID: 28855064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in price elasticities of demand for health insurance: a systematic review.
    Pendzialek JB; Simic D; Stock S
    Eur J Health Econ; 2016 Jan; 17(1):5-21. PubMed ID: 25398619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumer price sensitivity and social health insurer choice in Germany and The Netherlands.
    Schut FT; Gress S; Wasem J
    Int J Health Care Finance Econ; 2003 Jun; 3(2):117-38. PubMed ID: 14626009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching costs in competitive health insurance markets: The role of insurers' pricing strategies.
    Lamiraud K; Stadelmann P
    Health Econ; 2020 Sep; 29(9):992-1012. PubMed ID: 32542729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization.
    Keegan C; Teljeur C; Turner B; Thomas S
    Eur J Health Econ; 2016 Sep; 17(7):823-31. PubMed ID: 26359243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumer-oriented health care reform strategies: a review of the evidence on managed competition and consumer-directed health insurance.
    Buchmueller TC
    Milbank Q; 2009 Dec; 87(4):820-41. PubMed ID: 20021587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
    Brouns C; Douven R; Kemp R
    Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three years in - changing plan features in the U.S. health insurance marketplace.
    McKillop CN; Waters TM; Kaplan CM; Kaplan EK; Thompson MP; Graetz I
    BMC Health Serv Res; 2018 Jun; 18(1):450. PubMed ID: 29902996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.